Get Live Data
Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

Mon, 27th Feb 2023 09:26

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

SocGen raises Rolls-Royce price target to 148 pence - 'hold'

----------

Bank of America raises Rolls-Royce to 'buy' (underperform) - price target 175 (97) pence

----------

Jefferies raises Rolls-Royce price target to 170 (125) pence - 'buy'

----------

Jefferies raises BAE Systems price target to 1,060 (1,000) pence - 'buy'

----------

SocGen raises BAE Systems price target to 1,086 pence - 'buy'

----------

Bank of America raises International Consolidated Airlines price target to 240 (200) pence - 'buy'

----------

Barclays raises International Consolidated Airlines price target to 165 (160) pence - 'equal weight'

----------

Bernstein raises International Consolidated Airlines price target to 190 (180) pence - 'outperform'

----------

Goldman Sachs raises BP price target to 740 (690) pence - 'conviction buy list'

----------

Goldman Sachs raises Shell to 'buy' (neutral) - price target 40 (35) EUR

----------

Goldman Sachs raises Vodafone price target to 130 (120) pence - 'buy'

----------

Jefferies cuts Mondi price target to 1,710 (1,730) pence - 'buy'

----------

Jefferies cuts British American Tobacco price target to 4,100 (4,700) pence - 'buy'

----------

Jefferies cuts Imperial Brands price target to 1,993 (2,007) pence - 'hold'

----------

HSBC raises Rightmove to 'hold' - price target 530 pence

----------

Barclays cuts Anglo American price target to 2,900 (3,250) pence - 'equal weight'

----------

Goldman Sachs reinitiates GSK with 'buy' - price target 2,000 pence

----------

Citigroup cuts Hargreaves Lansdown to 'sell' - price target 730 pence

----------

JPMorgan raises Lloyds price target to 61 (58) pence - 'neutral'

----------

JPMorgan raises NatWest price target to 340 (330) pence - 'neutral'

----------

JPMorgan raises Barclays price target to 240 (230) pence - 'overweight'

----------

Deutsche Bank raises Standard Chartered price target to 890 (800) pence - 'hold'

----------

Barclays raises Prudential price target to 1,750 (1,518) pence - 'overweight'

----------

FTSE 250

----------

Citigroup cuts Quilter to 'sell' - price target 75 pence

----------

Berenberg raises Hikma Pharmaceutical target to 1,740 (1,440) pence - 'hold'

----------

Barclays raises Jupiter Fund price target to 130 (120) pence - 'equal weight'

----------

Peel Hunt cuts Howden Joinery Group to 'add' (buy) - price target 770 (700) pence

----------

Deutsche Bank raises Trainline to 'buy' (hold) - price target 287 (350) pence

----------

Jefferies raises Senior price target to 195 (180) pence - 'buy'

----------

SMALL CAP

----------

Berenberg cuts Resolute Mining price target to 24 (25) pence - 'buy'

----------

Jefferies raises Conduit Holdings price target to 650 (620) pence - 'buy'

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more
23 Aug 2023 08:17

GSK gets positive results from shingles trial of Shingrix in China

(Alliance News) - GSK PLC on Wednesday celebrated positive results from the first-ever efficacy trial of its preventative shingles treatment, Shingrix, in China.

Read more
23 Aug 2023 07:04

GSK reports positive results from shingles vaccine trials in China

(Sharecast News) - GSK reported significant positive findings from its first efficacy trial of the 'Shingrix' shingles vaccine in China on Wednesday.

Read more
22 Aug 2023 13:09

UK's Wood Group raises profit forecast on contract wins; shares rise

CFO David Kemp to retire

*

Read more
21 Aug 2023 22:37

US FDA approves Pfizer's maternal RSV vaccine to protect infants

Aug 21 (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.

Read more
17 Aug 2023 19:53

Charity says HIV drug deal with GSK's ViiV on ice over price secrecy

(Alliance News) - The Doctors Without Borders, or MSF, charity said Thursday a deal aimed to bring long-term preventative HIV treatment to vulnerable populations was on hold after the drugmaker imposed pricing confidentiality.

Read more
131415161718192021

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.